{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:52:02Z","timestamp":1785261122869,"version":"3.55.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jsps.2022.03.010","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T03:00:16Z","timestamp":1647313216000},"page":"655-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development"],"prefix":"10.1007","volume":"30","author":[{"given":"Ahmad M.","family":"Aldossary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinedu S.M.","family":"Ekweremadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifunanya M.","family":"Offe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya A.","family":"Alfassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyeon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian C.","family":"Onyali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuebuka H.","family":"Ozoude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel A.","family":"Ayeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinekwu S.","family":"Nwagwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Halwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada H.","family":"Almozain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam A.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-012-9878-0","article-title":"Effect of Polysorbate 80 concentration on thermal and photostability of a monoclonal antibody","volume":"14","author":"Agarkhed","year":"2013","journal-title":"AAPS PharmSciTech."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0010","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1053\/gast.2002.36588","article-title":"Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells","volume":"123","author":"Allez","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0015","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"key":"10.1016\/j.jsps.2022.03.010_b0020","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1111\/j.1365-2621.2006.tb08893.x","article-title":"Maillard reaction products as encapsulants for fish oil powders","volume":"71","author":"Augustin","year":"2006","journal-title":"J. Food Sci."},{"key":"10.1016\/j.jsps.2022.03.010_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.09.023","article-title":"The biology of mucus: composition, synthesis and organization","volume":"124","author":"Bansil","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1-2","key":"10.1016\/j.jsps.2022.03.010_b0030","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2012.10.033","article-title":"Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies","volume":"441","author":"Barhate","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0035","doi-asserted-by":"crossref","first-page":"e1000902","DOI":"10.1371\/journal.ppat.1000902","article-title":"Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa","volume":"6","author":"Bergstrom","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/pharmaceutics11010005","article-title":"Biomedical applications of electrospun nanofibers: drug and nanoparticle delivery","volume":"11","author":"Bhattarai","year":"2018","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/mi.2015.32","article-title":"New developments in goblet cell mucus secretion and function","volume":"8","author":"Birchenough","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(90)90183-M","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee","volume":"8","author":"Black","year":"1990","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.jsps.2022.03.010_b0055","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1073\/pnas.1701410114","article-title":"Emerging infectious diseases: A proactive approach","volume":"114","author":"Bloom","year":"2017","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/mi.2007.9","article-title":"Terminology: nomenclature of mucosa-associated lymphoid tissue","volume":"1","author":"Brandtzaeg","year":"2008","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","article-title":"Materials for oral delivery of proteins and peptides","volume":"5","author":"Brown","year":"2020","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal Formulations in Clinical Use: An Updated Review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0075","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1325-z","article-title":"Nanoparticles: Oral Delivery for Protein and Peptide Drugs","volume":"20","author":"Cao","year":"2019","journal-title":"AAPS PharmSciTech."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0080","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/molecules22050857","article-title":"Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines","volume":"22","author":"Carabineiro","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/srep25876","article-title":"Liposome production by microfluidics: potential and limiting factors","volume":"6","author":"Carugo","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jsps.2022.03.010_b0090","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.addr.2009.07.013","article-title":"Electrohydrodynamics: A facile technique to fabricate drug delivery systems","volume":"61","author":"Chakraborty","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jsps.2022.03.010_b0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2018.01.027","article-title":"Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses","volume":"273","author":"Chen","year":"2018","journal-title":"J. Controlled Release :Oofficial J. Controlled Release Soc."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.22.012703.104522","article-title":"Starting at the beginning: new perspectives on the biology of mucosal T cells","volume":"22","author":"Cheroutre","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin. Cancer Research: Official J. American Assoc. Cancer Res."},{"key":"10.1016\/j.jsps.2022.03.010_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7774\/cevr.2013.2.2.97","article-title":"Viral vectors for vaccine applications","volume":"2","author":"Choi","year":"2013","journal-title":"Clin. Exp. Vaccine Res."},{"issue":"11","key":"10.1016\/j.jsps.2022.03.010_b0115","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/acs.molpharmaceut.8b00579","article-title":"Acetalated Dextran Microparticles for Codelivery of STING and TLR7\/8 Agonists","volume":"15","author":"Collier","year":"2018","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/microorganisms6030078","article-title":"The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human","volume":"6","author":"Corfield","year":"2018","journal-title":"Microorganisms."},{"issue":"1-2","key":"10.1016\/j.jsps.2022.03.010_b0125","doi-asserted-by":"crossref","first-page":"e982426","DOI":"10.4161\/21688370.2014.982426","article-title":"Roles and regulation of the mucus barrier in the gut","volume":"3","author":"Cornick","year":"2015","journal-title":"Tissue Barriers"},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.xphs.2020.11.015","article-title":"The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2010.55","article-title":"Topical immunization strategies. Topical Immunization Strategies","volume":"3","author":"Czerkinsky","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-065X.2006.00484.x","article-title":"Epithelia: lymphocyte interactions in the gut","volume":"215","author":"Dahan","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jsps.2022.03.010_b0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jconrel.2014.12.004","article-title":"Coaxial electrohydrodynamic atomization: microparticles for drug delivery applications","volume":"205","author":"Davoodi","year":"2015","journal-title":"J. Controlled Release : Official J. Controlled Release Soc."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/bj3480557","article-title":"Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems","volume":"348","author":"Deacon","year":"2000","journal-title":"Biochem. J."},{"issue":"32","key":"10.1016\/j.jsps.2022.03.010_b0155","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1016\/j.vaccine.2013.05.016","article-title":"Prospects for oral replicating adenovirus-vectored vaccines","volume":"31","author":"Deal","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jsps.2022.03.010_b0160","first-page":"97","article-title":"Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7","volume":"20","author":"Doavi","year":"2016","journal-title":"Iranian Biomed. J."},{"key":"10.1016\/j.jsps.2022.03.010_b0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3886(95)00041-8","article-title":"Electrospinning process and applications of electrospun fibers","volume":"35","author":"Doshi","year":"1995","journal-title":"J. Electrostat."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/mp3005098","article-title":"Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis","volume":"10","author":"Duong","year":"2013","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0175","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4161\/19490976.2014.972238","article-title":"Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa","volume":"5","author":"Dupont","year":"2014","journal-title":"Gut microbes."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0180","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00046.2013","article-title":"Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. American journal of physiology","volume":"305","author":"Ermund","year":"2013","journal-title":"Gastrointestinal Liver Physiol."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0185","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/iub.1374","article-title":"Keeping bugs in check: The mucus layer as a critical component in maintaining intestinal homeostasis","volume":"67","author":"Faderl","year":"2015","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0190","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"159","author":"Ferreccio","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jsps.2022.03.010_b0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-94-007-2869-1_8","article-title":"Inherited mitochondrial disorders","volume":"942","author":"Finsterer","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/molecules24010171","article-title":"Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities","volume":"24","author":"Fleck","year":"2019","journal-title":"Molecules (Basel, Switzerland)."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/ie50137a024","article-title":"The Spray Process of Drying","volume":"13","author":"Fleming","year":"1921","journal-title":"J. Ind. Eng. Chem."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tmaid.2016.07.008","article-title":"Re-born in the USA: Another cholera vaccine for travellers","volume":"14","author":"Freedman","year":"2016","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.jsps.2022.03.010_b0215","unstructured":"Frizzell, H. E., 2019. Understanding and Overcoming Barriers to Oral Immunization with Biomaterials and Applied Immunology."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.immunol.17.1.399","article-title":"Development and maturation of secondary lymphoid tissues","volume":"17","author":"Fu","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jsps.2022.03.010_b0225","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1016\/j.xphs.2017.06.013","article-title":"Electrospray Synthesis of Poly(lactide-co-glycolide) Nanoparticles Encapsulating Peptides to Enhance Proliferation of Antigen-Specific CD8(+) T Cells","volume":"106","author":"Furtmann","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"20","key":"10.1016\/j.jsps.2022.03.010_b0230","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/adhm.201600642","article-title":"Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure","volume":"5","author":"Gallovic","year":"2016","journal-title":"Adv. Healthcare Mater."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0235","doi-asserted-by":"crossref","first-page":"2000041","DOI":"10.1002\/anbr.202000041","article-title":"Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases","volume":"1","author":"Genito","year":"2021","journal-title":"Adv. Nanobiomed. Res."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0240","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"42","key":"10.1016\/j.jsps.2022.03.010_b0245","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/j.vaccine.2015.08.085","article-title":"Freeze-drying of live virus vaccines: a review","volume":"33","author":"Hansen","year":"2015","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/gmic.1.1.10470","article-title":"The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria","volume":"1","author":"Hansson","year":"2010","journal-title":"Gut microbes."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta pharmaceutica Sinica. B."},{"key":"10.1016\/j.jsps.2022.03.010_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080375","article-title":"Mucosal Vaccination via the Respiratory Tract","volume":"11","author":"Hellfritzsch","year":"2019","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jsps.2022.03.010_b0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.nutr.22.011602.092259","article-title":"How host-microbial interactions shape the nutrient environment of the mammalian intestine","volume":"22","author":"Hooper","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.jsps.2022.03.010_b0275","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fphar.2020.00524","article-title":"Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors","volume":"11","author":"Hua","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/scipharm87040027","article-title":"Recent Approaches for Solid Dose Vaccine Delivery","volume":"87","author":"Jahan","year":"2019","journal-title":"Sci. Pharm."},{"issue":"16","key":"10.1016\/j.jsps.2022.03.010_b0285","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1073\/pnas.0400969101","article-title":"Intestinal villous M cells: an antigen entry site in the mucosal epithelium","volume":"101","author":"Jang","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.jsps.2022.03.010_b0290","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.elstat.2007.10.001","article-title":"Electrospraying route to nanotechnology: an overview","volume":"66","author":"Jaworek","year":"2008","journal-title":"J. Electrostat."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2012.04.015","article-title":"Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles","volume":"161","author":"Jazayeri","year":"2012","journal-title":"J. Controlled Release : Official J. Controlled Release Soc."},{"key":"10.1016\/j.jsps.2022.03.010_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.682286","article-title":"Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases","volume":"12","author":"Jazayeri","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.jsps.2022.03.010_b0305","doi-asserted-by":"crossref","first-page":"e41009","DOI":"10.1371\/journal.pone.0041009","article-title":"Fast renewal of the distal colonic mucus layers by the surface goblet cells as measured by in vivo labeling of mucin glycoproteins","volume":"7","author":"Johansson","year":"2012","journal-title":"PLoS ONE"},{"issue":"22","key":"10.1016\/j.jsps.2022.03.010_b0310","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s00018-011-0822-3","article-title":"Composition and functional role of the mucus layers in the intestine","volume":"68","author":"Johansson","year":"2011","journal-title":"Cellular Mol. Life Sci.: CMLS"},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","article-title":"Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis","volume":"63","author":"Johansson","year":"2014","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jsps.2022.03.010_b0320","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nri.2016.88","article-title":"Immunological aspects of intestinal mucus and mucins","volume":"16","author":"Johansson","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.jsps.2022.03.010_b0325","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1073\/pnas.1006451107","article-title":"The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions","volume":"108","author":"Johansson","year":"2011","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0330","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","article-title":"The gastrointestinal mucus system in health and disease","volume":"10","author":"Johansson","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsps.2022.03.010_b0335","doi-asserted-by":"crossref","unstructured":"Johnson, S., Martinez, C., Cortese, M., et al., 2021. 589. Oral Tablet Vaccination Induces Heightened Cross-Reactive CD8 T Cell Responses to SARS-COV-2 in Humans. Open Forum Infectious Diseases. 8, S397-S397. https:\/\/doi.org\/10.1093\/ofid\/ofab466.787.","DOI":"10.1093\/ofid\/ofab466.787"},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0340","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2144\/000112593","article-title":"Long-term storage of DNA-free RNA for use in vaccine studies","volume":"43","author":"Jones","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.jsps.2022.03.010_b0345","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0376-7388(99)00334-8","article-title":"Membrane emulsification \u2014 a literature review","volume":"169","author":"Joscelyne","year":"2000","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.jsps.2022.03.010_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2017.11.030","article-title":"A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination","volume":"270","author":"Junkins","year":"2018","journal-title":"J. Controlled Release : Official J. Controlled Release Soc."},{"issue":"7","key":"10.1016\/j.jsps.2022.03.010_b0355","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/17425247.2021.1828860","article-title":"Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies","volume":"18","author":"Kang","year":"2021","journal-title":"Expert Opinion Drug Delivery"},{"issue":"9","key":"10.1016\/j.jsps.2022.03.010_b0360","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/polym10090948","article-title":"Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting","volume":"10","author":"Kang","year":"2018","journal-title":"Polymers"},{"issue":"10","key":"10.1016\/j.jsps.2022.03.010_b0365","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1080\/21645515.2017.1356952","article-title":"Developments in the formulation and delivery of spray dried vaccines","volume":"13","author":"Kanojia","year":"2017","journal-title":"Human Vaccines & Immunotherapeutics."},{"key":"10.1016\/j.jsps.2022.03.010_b0370","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2015.02.063","article-title":"Microfluidic-controlled manufacture of liposomes for the solubilization of a poorly water soluble drug","volume":"485","author":"Kastner","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"13","key":"10.1016\/j.jsps.2022.03.010_b0375","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121077","article-title":"Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial","volume":"3","author":"Kim","year":"2018","journal-title":"JCI Insight."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0380","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11894-010-0131-2","article-title":"Intestinal goblet cells and mucins in health and disease: recent insights and progress","volume":"12","author":"Kim","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"9","key":"10.1016\/j.jsps.2022.03.010_b0385","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.jsps.2022.03.010_b0390","first-page":"E86","article-title":"Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation","volume":"1207","author":"Koboziev","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1196\/annals.1366.024","article-title":"Immunomodulatory properties of substance P: the gastrointestinal system as a model","volume":"1088","author":"Koon","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0400","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/all.14722","article-title":"COVID-19 vaccine anaphylaxis: PEG or not?","volume":"76","author":"Krantz","year":"2021","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0405","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.addr.2012.11.003","article-title":"Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract","volume":"65","author":"Kriegel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0410","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.addr.2011.07.003","article-title":"Gut-associated lymphoid tissues for the development of oral vaccines","volume":"64","author":"Kunisawa","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0415","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/eji.200323383","article-title":"Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice","volume":"33","author":"Kunkel","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jsps.2022.03.010_b0420","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune network."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0425","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/vaccines8020304","article-title":"Technological Approaches for Improving Vaccination Compliance and Coverage","volume":"8","author":"Lemoine","year":"2020","journal-title":"Vaccines."},{"key":"10.1016\/j.jsps.2022.03.010_b0430","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0435","article-title":"The outer mucus layer hosts a distinct intestinal microbial niche","volume":"6","author":"Li","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jsps.2022.03.010_b0440","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejpb.2015.09.018","article-title":"A lipid based multi-compartmental system: Liposomes-in-double emulsion for oral vaccine delivery","volume":"97","author":"Liau","year":"2015","journal-title":"European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0445","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(19)30584-5","article-title":"Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study","volume":"20","author":"Liebowitz","year":"2020","journal-title":"Lancet. Infect. Dis"},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0450","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jmv.23768","article-title":"Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection","volume":"86","author":"Liu","year":"2014","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0455","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines7020037","article-title":"A Comparison of Plasmid DNA and mRNA as Vaccine Technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0460","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00893-4","article-title":"Microfluidic transfection of mRNA into human primary lymphocytes and hematopoietic stem and progenitor cells using ultra-fast physical deformations","volume":"11","author":"Loo","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0465","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11095-016-1860-1","article-title":"Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying","volume":"33","author":"Lovalenti","year":"2016","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.jsps.2022.03.010_b0470","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1-2","key":"10.1016\/j.jsps.2022.03.010_b0475","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijpharm.2014.06.052","article-title":"M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity","volume":"473","author":"Ma","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsps.2022.03.010_b0480","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biomaterials.2016.01.043","article-title":"Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum","volume":"84","author":"Maharjan","year":"2016","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.jsps.2022.03.010_b0485","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1586\/14760584.2014.936852","article-title":"Oral delivery of nanoparticle-based vaccines","volume":"13","author":"Marasini","year":"2014","journal-title":"Expert Review Vaccines"},{"issue":"8","key":"10.1016\/j.jsps.2022.03.010_b0490","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41579-018-0036-x","article-title":"Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier","volume":"16","author":"Martens","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jsps.2022.03.010_b0495","first-page":"32","article-title":"Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells","volume":"66","author":"Matsumoto","year":"1989","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.jsps.2022.03.010_b0500","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1586\/erv.12.101","article-title":"Spray drying and vaccine stabilization","volume":"11","author":"McAdams","year":"2012","journal-title":"Expert Review Vaccines"},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0505","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(92)90021-B","article-title":"The mucosal immune system: from fundamental concepts to vaccine development","volume":"10","author":"McGhee","year":"1992","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.jsps.2022.03.010_b0510","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1039\/D0BM01433H","article-title":"Thermostabilization of viruses via complex coacervation","volume":"8","author":"Mi","year":"2020","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(00)00142-X","article-title":"A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection","volume":"49","author":"Mohamedi","year":"2001","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jsps.2022.03.010_b0520","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jconrel.2020.10.046","article-title":"Protein encapsulation by electrospinning and electrospraying","volume":"329","author":"Moreira","year":"2021","journal-title":"J. Controlled Release: Official J. Controlled Release Soc."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0525","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1057","article-title":"Anatomical basis of tolerance and immunity to intestinal antigens","volume":"3","author":"Mowat","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.jsps.2022.03.010_b0530","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0535","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in vitro testing","volume":"7","author":"Mudie","year":"2010","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0540","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jsps.2022.03.010_b0545","doi-asserted-by":"crossref","unstructured":"New, R., 2019. Formulation technologies for oral vaccines. Clinical & Experimental Immunology. 198, 153-169.","DOI":"10.1111\/cei.13352"},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0550","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.0105-2896.2005.00282.x","article-title":"Organizing a mucosal defense","volume":"206","author":"Newberry","year":"2005","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.jsps.2022.03.010_b0555","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.xphs.2016.04.024","article-title":"Pharmaceutical Applications of Electrospraying","volume":"105","author":"Nguyen","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0560","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mog.0000231807.03149.54","article-title":"Dendritic cells: the commanders-in-chief of mucosal immune defenses","volume":"22","author":"Niess","year":"2006","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0565","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.vaccine.2009.11.024","article-title":"Heat-stable measles vaccine produced by spray drying","volume":"28","author":"Ohtake","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jsps.2022.03.010_b0570","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4161\/hv.6.12.13142","article-title":"Mucosal immunization: a realistic alternative","volume":"6","author":"Otczyk","year":"2010","journal-title":"Human Vaccines"},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0575","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.it.2008.02.006","article-title":"Tissue distribution of lymphocytes and plasma cells and the role of the gut","volume":"29","author":"Pabst","year":"2008","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0580","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.jsps.2022.03.010_b0585","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.matdes.2017.04.029","article-title":"Performance of novel high throughput multi electrospray systems for forming of polymeric micro\/nanoparticles","volume":"126","author":"Parhizkar","year":"2017","journal-title":"Mater. Des."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0590","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4155\/tde.14.5","article-title":"Recent developments in protein and peptide parenteral delivery approaches","volume":"5","author":"Patel","year":"2014","journal-title":"Therapeutic Delivery"},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0595","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","article-title":"New insights in mucosal vaccine development","volume":"30","author":"Pavot","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jsps.2022.03.010_b0600","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","article-title":"Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: strategies and industrial perspectives","volume":"196","author":"Pawar","year":"2014","journal-title":"J. Controlled Release : Official J.Controlled Release Soc."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12182","article-title":"The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system","volume":"260","author":"Pelaseyed","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jsps.2022.03.010_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/789289","article-title":"A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications","volume":"2013","author":"Pillay","year":"2013","journal-title":"J. Nanomater."},{"key":"10.1016\/j.jsps.2022.03.010_b0615","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2021.01.016","article-title":"Stability of lyophilized and spray dried vaccine formulations","volume":"171","author":"Preston","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jsps.2022.03.010_b0620","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2021.01.003","article-title":"Advances in gene-based vaccine platforms to address the COVID-19 pandemic","volume":"170","author":"Pushparajah","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0625","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/21645515.2019.1575165","article-title":"A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children","volume":"15","author":"Raqib","year":"2019","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.jsps.2022.03.010_b0630","doi-asserted-by":"crossref","first-page":"004","DOI":"10.17352\/jvi.000038","article-title":"Vaccine development and delivery strategies\u2013A glimpse","volume":"7","author":"Rashmi","year":"2021","journal-title":"J. Vaccines Immunol."},{"key":"10.1016\/j.jsps.2022.03.010_b0635","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","article-title":"New Vaccine Technologies to Combat Outbreak Situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.jsps.2022.03.010_b0640","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jsps.2022.03.010_b0645","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.2174\/15680266113136660183","article-title":"Vaccine adjuvants: key tools for innovative vaccine design","volume":"13","author":"Riese","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0650","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2648.2000.01312.x","article-title":"Drawing up and administering intramuscular injections: a review of the literature","volume":"31","author":"Rodger","year":"2000","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.jsps.2022.03.010_b0655","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2049-1891-4-27","article-title":"The immune modifying effects of amino acids on gut-associated lymphoid tissue","volume":"4","author":"Ruth","year":"2013","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.jsps.2022.03.010_b0660","doi-asserted-by":"crossref","unstructured":"Schiffter, H., 2011. The delivery of drugs\u2013peptides and proteins.","DOI":"10.1016\/B978-0-444-64046-8.00309-8"},{"issue":"11","key":"10.1016\/j.jsps.2022.03.010_b0665","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-vaccine technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol."},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0670","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Therapeutic advances in vaccines."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0675","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines6020029","article-title":"Clinical Advances in Viral-Vectored Influenza Vaccines","volume":"6","author":"Sebastian","year":"2018","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0680","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut Microbiota in Health and Disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0685","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cea.14064","article-title":"The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients","volume":"52","author":"Sellaturay","year":"2022","journal-title":"Clin. Exp. Allergy : J. Br. Soc. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0690","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0105-2896.2005.00295.x","article-title":"Non-classical MHC class I molecules on intestinal epithelial cells: mediators of mucosal crosstalk","volume":"206","author":"Shao","year":"2005","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0695","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biotechadv.2007.01.005","article-title":"Immunogenicity of therapeutic proteins. Part 1: impact of product handling","volume":"25","author":"Sharma","year":"2007","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0700","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biotechadv.2014.12.004","article-title":"Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities","volume":"33","author":"Sharma","year":"2015","journal-title":"Biotechnol. Adv."},{"issue":"13","key":"10.1016\/j.jsps.2022.03.010_b0705","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1021\/acs.nanolett.1c01353","article-title":"Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device","volume":"21","author":"Shepherd","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jsps.2022.03.010_b0710","first-page":"263","article-title":"Review on structure, function and applications of microfluidic systems","volume":"4","author":"Shirzadfar","year":"2018","journal-title":"Int. J. Boisen. Bioelectron."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0715","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-018-1262-2","article-title":"Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances","volume":"20","author":"Shreya","year":"2019","journal-title":"AAPS PharmSciTech."},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0720","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18433\/J3K01M","article-title":"Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes)","volume":"11","author":"Shukla","year":"2008","journal-title":"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques."},{"issue":"13","key":"10.1016\/j.jsps.2022.03.010_b0725","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.biomaterials.2008.01.011","article-title":"Electrospinning: applications in drug delivery and tissue engineering","volume":"29","author":"Sill","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jsps.2022.03.010_b0730","first-page":"100080","article-title":"Infectious disease and economics: The case for considering multi-sectoral impacts","volume":"7","author":"Smith","year":"2019","journal-title":"One health (Amsterdam, Netherlands)"},{"key":"10.1016\/j.jsps.2022.03.010_b0735","doi-asserted-by":"crossref","first-page":"110070","DOI":"10.1016\/j.msec.2019.110070","article-title":"Electrospray for generation of drug delivery and vaccine particles applied in vitro and in vivo","volume":"105","author":"Steipel","year":"2019","journal-title":"Mater. Sci. Eng. C, Mater. Biological Appl."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0740","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease","volume":"14","author":"Strebel","year":"1992","journal-title":"Clin. Infect. Dis: Off. Publication Infect. Diseases Soc. America"},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0745","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2013.03.015","article-title":"Methylated N-(4-N, N-dimethylaminocinnamyl) chitosan-coated electrospray OVA-loaded microparticles for oral vaccination","volume":"448","author":"Suksamran","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jsps.2022.03.010_b0750","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1080\/21645515.2017.1330236","article-title":"Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity","volume":"13","author":"Suschak","year":"2017","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.jsps.2022.03.010_b0755","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2017.10.014","article-title":"A slippery slope: On the origin, role and physiology of mucus","volume":"124","author":"Taherali","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7156","key":"10.1016\/j.jsps.2022.03.010_b0760","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nature06033","article-title":"Regulation of IgA production by naturally occurring TNF\/iNOS-producing dendritic cells","volume":"448","author":"Tezuka","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jsps.2022.03.010_b0765","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ijbiomac.2018.10.144","article-title":"Complex coacervation: Principles, mechanisms and applications in microencapsulation","volume":"121","author":"Timilsena","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0770","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in Viral Vector-Based Vaccines. Developments in Viral Vector-Based Vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.jsps.2022.03.010_b0775","doi-asserted-by":"crossref","first-page":"e47511","DOI":"10.1371\/journal.pone.0047511","article-title":"A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jsps.2022.03.010_b0780","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","article-title":"Current state and challenges in developing oral vaccines","volume":"114","author":"Vela Ramirez","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl. 5","key":"10.1016\/j.jsps.2022.03.010_b0785","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1469-0691.2012.03981.x","article-title":"Rotavirus vaccination: a concise review","volume":"18","author":"Vesikari","year":"2012","journal-title":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases."},{"issue":"9","key":"10.1016\/j.jsps.2022.03.010_b0790","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1084\/jem.20122465","article-title":"A role for gut-associated lymphoid tissue in shaping the human B cell repertoire","volume":"210","author":"Vossenk\u00e4mper","year":"2013","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.jsps.2022.03.010_b0795","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and Challenges in the Delivery of mRNA-based Vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jsps.2022.03.010_b0800","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-0363-4_6","article-title":"Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications","volume":"1141","author":"Walsh","year":"2014","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"issue":"18","key":"10.1016\/j.jsps.2022.03.010_b0805","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.vaccine.2010.02.058","article-title":"Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jsps.2022.03.010_b0810","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/14760584.7.6.729","article-title":"Oral vaccine delivery: can it protect against non-mucosal pathogens?","volume":"7","author":"Wang","year":"2008","journal-title":"Expert Review Vaccines"},{"issue":"1","key":"10.1016\/j.jsps.2022.03.010_b0815","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejpb.2014.04.007","article-title":"Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system","volume":"88","author":"Wang","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.jsps.2022.03.010_b0820","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13238-015-0164-2","article-title":"Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies","volume":"6","author":"Wang","year":"2015","journal-title":"Protein & Cell"},{"key":"10.1016\/j.jsps.2022.03.010_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-35761-6.00067-5","article-title":"Development of Gene-Based Vectors for Immunization","volume":"1305\u20131319","author":"Weiner","year":"2018","journal-title":"Plotkin's Vaccines"},{"key":"10.1016\/j.jsps.2022.03.010_b0830","doi-asserted-by":"crossref","unstructured":"Wershil, B.K., Furuta, G.T., 2008. Gastrointestinal mucosal immunity. The Journal of allergy and clinical immunology. 121, S380-383; quiz S415. https:\/\/doi.org\/10.1016\/j.jaci.2007.10.023.","DOI":"10.1016\/j.jaci.2007.10.023"},{"issue":"3","key":"10.1016\/j.jsps.2022.03.010_b0835","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/1061186X.2012.747528","article-title":"Characterization and optimization of bilosomes for oral vaccine delivery","volume":"21","author":"Wilkhu","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jsps.2022.03.010_b0840","series-title":"Nanofibres in Drug Delivery","year":"2018"},{"key":"10.1016\/j.jsps.2022.03.010_b0845","unstructured":"World Health Organization, 2010. Cholera vaccines: WHO position paper. Weekly Epidemiological Record. 85, 117-128."},{"key":"10.1016\/j.jsps.2022.03.010_b0850","unstructured":"World Health Organization, 2013. Rotavirus vaccines. WHO position paper Weekly Epidemiological Record. 88, 49-64."},{"key":"10.1016\/j.jsps.2022.03.010_b0855","unstructured":"World Health Organization, 2014. Polio vaccines: WHO position paper. Weekly Epidemiological Record. 89, 73-92."},{"issue":"5","key":"10.1016\/j.jsps.2022.03.010_b0860","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1163\/156856208784089616","article-title":"Electrohydrodynamic atomization: a versatile process for preparing materials for biomedical applications","volume":"19","author":"Wu","year":"2008","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"4","key":"10.1016\/j.jsps.2022.03.010_b0865","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"Zaiss","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jsps.2022.03.010_b0870","first-page":"2997","article-title":"Advances in drug delivery via electrospun and electrosprayed nanomaterials","volume":"8","author":"Zamani","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jsps.2022.03.010_b0875","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA Vaccines for Infectious Diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jsps.2022.03.010_b0880","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3390\/pharmaceutics12111068","article-title":"The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles","volume":"12","author":"Zukancic","year":"2020","journal-title":"Pharmaceutics"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642200069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642200069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:27:57Z","timestamp":1736184477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S131901642200069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":176,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S131901642200069X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2022.03.010","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2022.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}